Browse

Consensus statement on iron overload in myelodysplastic syndromes

Cited 119 time in Web of Science Cited 145 time in Scopus
Authors
Bennett, John M
Issue Date
2008-09-04
Publisher
Wiley-Blackwell
Citation
Am J Hematol. 2008 ;83(11):858-61.
Keywords
Chelation Therapy/*standardsErythrocyte Transfusion/adverse effects/*standardsFerritins/bloodHumansIron/metabolismIron Overload/etiology/*prevention & controlMyelodysplastic Syndromes/*therapy
Abstract
In May 2005 at the 8th International Symposium on Myelodysplastic Syndromes (MDS), a consensus meeting was held on iron overload in MDS (Seymour, Hematol Oncol Clin 2005; Suppl 1:18-25). The recommendations of the 2005 consensus meeting were discussed in the context of currently available evidence at the 9th International Symposium on Myelodysplastic Syndromes in Florence Italy, May 2007. The recommendations of the consensus working group are presented here. The recommendations are a continued refinement of the outcome of the 2005 consensus meeting and the ground-breaking work of others in this area (Seymour, Hematol Oncol Clin 2005; Suppl 1:18-25; Gattermann, Int J Hematol 2008;88:24-29; Alessandrino et al., Haematologica 2002;87:1286-1306; NCCN practice guidelines: Myelodysplastic Syndromes, version 2.2008).
ISSN
1096-8652 (Electronic)
Language
English
URI
http://hdl.handle.net/10371/62224
DOI
https://doi.org/10.1002/ajh.21269
Files in This Item:
There are no files associated with this item.
Appears in Collections:
College of Medicine/School of Medicine (의과대학/대학원)Internal Medicine (내과학전공)Journal Papers (저널논문_내과학전공)
  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse